Shares of Fresenius Medical Care AG (NYSE:FMS) saw unusually-high trading volume on Thursday . Approximately 257,391 shares traded hands during trading, an increase of 62% from the previous session’s volume of 158,433 shares.The stock last traded at $46.31 and had previously closed at $46.20.

FMS has been the subject of a number of recent research reports. DZ Bank AG reissued a “sell” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 10th. Robert W. Baird reissued a “hold” rating on shares of Fresenius Medical Care AG in a report on Monday, May 16th. Jefferies Group raised Fresenius Medical Care AG from an “underperform” rating to a “hold” rating in a report on Friday, July 8th. Royal Bank Of Canada restated a “hold” rating on shares of Fresenius Medical Care AG in a research note on Tuesday, May 24th. Finally, Zacks Investment Research upgraded Fresenius Medical Care AG from a “sell” rating to a “hold” rating in a research note on Wednesday, May 4th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $42.50.

The stock has a market cap of $27.32 billion and a price-to-earnings ratio of 24.77. The company’s 50-day moving average is $45.05 and its 200-day moving average is $43.44.

Fresenius Medical Care AG (NYSE:FMS) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.92 by $0.04. The company earned $4.42 billion during the quarter, compared to analysts’ expectations of $4.54 billion. Analysts expect that Fresenius Medical Care AG will post $2.01 EPS for the current year.

Several institutional investors have made changes to their positions in the stock. Bank of Montreal Can increased its position in shares of Fresenius Medical Care AG by 60.0% in the fourth quarter. Bank of Montreal Can now owns 56,700 shares of the company’s stock worth $2,373,000 after buying an additional 21,264 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Fresenius Medical Care AG by 3.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 107,376 shares of the company’s stock worth $4,493,000 after buying an additional 3,694 shares in the last quarter. Finally, Morgan Stanley increased its position in shares of Fresenius Medical Care AG by 20.5% in the fourth quarter. Morgan Stanley now owns 685,338 shares of the company’s stock worth $28,675,000 after buying an additional 116,653 shares in the last quarter.

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.